Oleg Frumuzachi

Mr. Oleg Frumuzachi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
OFOleg Frumuzachi
Oleg Frumuzachi
LGLaura Ioana Gavrilas
Laura Ioana Gavrilas
Dan Cristian VodnarDan Cristian Vodnar
Dan Cristian Vodnar
Sascha RohnSascha Rohn
Sascha Rohn
Andrei-Marius MocanAndrei-Marius Mocan
Andrei-Marius Mocan
Non-communicable diseases (NCDs) cause 41 million deaths annually, accounting for 74% of global fatalities. The so-called Mediterranean diet, with its especially significant consumption of olive oil, has shown promising results in reducing the risk of developing NCDs, such as cardiovascular, liver, or bone diseases. In the context of the nutritional health benefits of foods, phenolic compounds such as olive oil’s main components, oleuropein (OLE) and hydroxytyrosol (HT), have been shown to possess different beneficial effects. However, no systematic review has evaluated the health-promoting effects of OLE and HT until now. Consequently, this systematic review analyzed 12 human randomized controlled trials (RCTs), involving 683 participants, to assess the effects of supplements, pure compounds, or enriched foods containing OLE and HT regarding systemic health outcomes, including CVD risk factors, liver parameters, and bone, joint, and cognitive health. The review found contrasting but encouraging results, with some studies reporting significant modulation of body weight, lipid profile, and glucose metabolism, and improvements in bone, joint, and cognitive functions. The studies described different dosages and forms of supplementation, ranging from 5 mg/d HT to 990 mL/d olive leaf infusion (320.8 mg OLE and 11.9 mg HT), highlighting the need for further research to determine the optimal dosing and duration. Despite the mixed outcomes, OLE and HT supplementation show potential for improving some of the cardiometabolic health outcomes and bone, joint, and cognitive health. However, further studies are necessary to understand their benefits better and address existing limitations.

28 July 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
CMCadmiel Moldovan
Cadmiel Moldovan
OFOleg Frumuzachi
Oleg Frumuzachi
Mihai BabotăMihai Babotă
Mihai Babotă
Lillian BarrosLillian Barros
Lillian Barros
Andrei-Marius MocanAndrei-Marius Mocan
Andrei-Marius Mocan
GCGianina Crişan
Gianina Crişan
Background: Shallot (Allium ascalonicumL.) is a traditional plant species used throughout the world both for culinary purposes and as a folk remedy. To date (i.e., April 2022), there is no report on the main pharmacological activities exerted by shallot preparations and/or extracts.Scope and Approach: The aim of this study was to comprehensively review the pharmacological activities exerted by shallot, with rigorous inclusion and exclusion criteria based on the scientific rigor of studies. Prisma guidelines were followed to perform the literature search.Key Findings and Conclusions: The literature search yielded 2,410 articles of which 116 passed the required rigorous criteria for inclusion in this review. The extracts exert a potent antioxidant activity bothin vitroandin vivo, as well as a strong inhibitory capacity on various pathogens with relevant implications for public health. Moreover, shallot can be used as adjuvant therapy in cardiovascular diseases, diabetes, cancer prevention, and other non-communicable diseases associated with inflammatory and oxidative pathways. Future studies investigating the chemical composition of this species, as well as the molecular mechanisms involved in the empirically observed pharmacological actions are required.

14 March 2025 in Food Research International
Verified
Journal Article
Open access
OFOleg Frumuzachi
Oleg Frumuzachi
AFAlan Flanagan
Alan Flanagan
Sascha RohnSascha Rohn
Sascha Rohn
Andrei-Marius MocanAndrei-Marius Mocan
Andrei-Marius Mocan
Diet is one of the main drivers of non-communicable chronic diseases (NCD). Modifying the food supply may be an attractive strategy for promoting health and reducing NCD risk. The intentional modification, processing, enrichment, or fortification of foods to produce "functional foods" currently varies according to legal definitions and existing regulatory frameworks, initially intended function, and production methods. This review critically appraises the existing definitions and concepts applied to functional foods, proposing a new concept of "functionalized foods". The conceptual difference between the two categories is that the term "functional foods" is used for products validated for human health through controlled trials, while "functionalized foods" is used for food products obtained through enrichment or (bio)fortification that lack such a validation, yet. Consequently, the review aims to establish a framework for better understanding the range of existing products, enhancing communication, and promoting a more accurate interpretation of the functional food landscape.

7 October 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
CMCadmiel Moldovan
Cadmiel Moldovan
OFOleg Frumuzachi
Oleg Frumuzachi
Mihai BabotăMihai Babotă
Mihai Babotă
LUIGI MENGHINILUIGI MENGHINI
LUIGI MENGHINI
Stefania CesaStefania Cesa
Stefania Cesa
Lillian BarrosLillian Barros
Lillian Barros
Hot air drying has proven to be an efficient method to preserve specific edible plant materials with medicinal properties. This is a process involving chemical, physical, and biological changes in plant matrices. Understanding these processes will lead to an improvement in the yields of bioactive compounds. This study aims to optimize the drying process of two species’ fruits used in folk medicine, Berberis vulgaris and Crataegus monogyna. The optimized extracts’ antioxidant capacity was assessed using various assays, with the barberry extract showing very good activity (50.85, 30.98, and 302.45 mg TE/g dw for DPPH, TEAC, and FRAP assays, respectively). Both species exerted good fungal α-glucosidase inhibitory activity (IC50 = 0.34 and 0.56 mg/mL, respectively) but no activity on mammalian α-glucosidase. Additionally, this study identified and quantified the main bioactive compounds. The results presented herein are a breakthrough in industrializing this drying process. Additional studies are necessary to mechanistically understand the drying process involved in these plant materials.

20 September 2024 in Food Research International
Verified
Journal Article
Open access
OFOleg Frumuzachi
Oleg Frumuzachi
Sascha RohnSascha Rohn
Sascha Rohn
Andrei-Marius MocanAndrei-Marius Mocan
Andrei-Marius Mocan
Black chokeberry (Aronia melanocarpa (Michx.) Elliott) is recognized for its potential health benefits, largely attributed to its high phenolic content. However, many phenolic compounds possess a low bioavailability, potentially limiting their beneficial effects. Fermentation of chokeberry has been proposed as a method to improve bioavailability, bioactive composition, sensory qualities, and nutritional value. This systematic review provides an overview of fermented chokeberry products, including compound composition, sensory attributes, and health benefits observed in in vivo and in vitro studies. While sensory evaluations highlighted diverse flavour profiles and acceptability, human intervention studies suggested potential benefits for glucose-dependent insulinotropic peptide increase. Animal models indicated anti-obesity and immunomodulatory properties, while in vitro studies demonstrate antioxidant, anti-melanogenesis, and anti-diabetic effects. Despite some promising findings in human and animal trials, challenges such as participant adherence and dosing inconsistencies force further protocol improvements. Through continuous scientific research, fermented chokeberry products may emerge as functional foods contributing to human health.

29 April 2022 in Plants
Verified
Journal Article
Open access
PDF file
Paltinean RamonaPaltinean Ramona
Paltinean Ramona
Irina IelciuIrina Ielciu
Irina Ielciu
Daniela HanganuDaniela Hanganu
Daniela Hanganu
Mihaela NiculaeMihaela Niculae
Mihaela Niculae
Emoke PallEmoke Pall
Emoke Pall
Michel FREDERICHMichel FREDERICH
Michel FREDERICH
Fumaria schleicheri Soy. Will. is a species belonging to the Papaveraceae family, being widespread in East-Central and Southern Europe. As with numerous other species of the genus, it is used in traditional medicine for the treatment of hepatobiliary and digestive disorders. The aim of the present study consisted of the evaluation of its alkaloid content and the assessment of its in vitro antioxidant, anti-cholinesterase and cytotoxic potential. Total alkaloid content in the composition of the species was quantified by a spectrophotometrical method and they were individually identified and quantified by HPLC-DAD. The antioxidant capacity was investigated by the DPPH and FRAP methods, while the anti-cholinesterase activity was assessed by an adapted Ellman’s method. The in vitro cytotoxic activity was evaluated on BJ human fibroblasts and DLD-1 human colon adenocarcinoma cell lines. Results showed the presence of bicuculline, protopine, chelidonine, stylopine and sanguinarine, among which bicuculline, protopine, stylopine and sanguinarine were quantified, while the antioxidant and anti-cholinesterase assays showed valuable potentials. No cytotoxic effect was observed on BJ cell lines and selective cytotoxicity was expressed towards tumoral cells. In this context, F. schleicheri appears as an important medicinal species with significant potential of substitution with the officinal species.